DexCom Inc. (DXCM)
66.14
-1.16 (-1.72%)
At close: Apr 11, 2025, 3:59 PM
66.22
0.12%
After-hours: Apr 11, 2025, 05:52 PM EDT
-1.72% (1D)
| Bid | 66.15 |
| Market Cap | 25.93B |
| Revenue (ttm) | 4.03B |
| Net Income (ttm) | 576.2M |
| EPS (ttm) | 1.42 |
| PE Ratio (ttm) | 46.58 |
| Forward PE | 43.93 |
| Analyst | Buy |
| Ask | 66.22 |
| Volume | 3,344,198 |
| Avg. Volume (20D) | 4,282,661 |
| Open | 67.23 |
| Previous Close | 67.30 |
| Day's Range | 65.00 - 67.66 |
| 52-Week Range | 57.52 - 139.24 |
| Beta | 1.50 |
About DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i...
Industry Medical - Devices
Sector Healthcare
IPO Date Apr 14, 2005
Employees 10,200
Stock Exchange NASDAQ
Ticker Symbol DXCM
Website https://www.dexcom.com
Analyst Forecast
According to 18 analyst ratings, the average rating for DXCM stock is "Buy." The 12-month stock price forecast is $99.5, which is an increase of 50.44% from the latest price.
Stock Forecasts2 days ago
+0.69%
Dexcom shares are trading higher after the company...
Unlock content with
Pro Subscription
3 weeks ago
+3.79%
DexCom shares are trading higher after the company announced it launched its first multi-region report.
